Aegis Ventures and Wavelet Medical Aim to Redefine the Standard of Care in Fetal Medicine
Wavelet is on a mission to eliminate preventable brain injury at birth and reduce unnecessary caesarean sections, improving the lives of babies and mothers around the world. NEW YORK, April 14, 2026 /PRNewswire/ — A breakthrough in fetal brain monitoring developed at... Read More →
Sibel Health Receives FDA-Clearance for ANNE® Maternal, a Comprehensive and Fully Wireless Maternal-Fetal Monitoring Platform
CHICAGO, April 9, 2026 /PRNewswire/ — Sibel Health today announced FDA 510(k) clearance of ANNE® Maternal, the world’s first fully wireless, comprehensive maternal-fetal monitoring platform. Designed for continuous, simultaneous monitoring of maternal and fetal health, ANNE® Maternal combines advanced wearable... Read More →
FDA Clears InVera Infusion Device to Treat Chronic Venous Disease
April 8, 2026—InVera Medical announced FDA 510(k) clearance for the InVera infusion device for the minimally invasive treatment of diseased leg veins, including varicose veins. The device is now approved for use in the United States and European Union within... Read More →
Validation of Velacur Liver Stiffness and Attenuation in Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease featuring Sonic Incytes Medical
Abstract Background and Aims As clinicians prepare to screen and manage the influx of patients with metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic dysfunction–associated steatohepatitis (MASH), new systems to help with patient assessment and management need to undergo rigorous... Read More →
Madorra Enrolls First Patient in Pivotal Trial for Treatment of Moderate to Severe Vulvovaginal Atrophy: The WAVES Study
Breakthrough Device-Designated Therapy System Takes Important Step Toward Market Authorization PORTLAND, OR, UNITED STATES, March 24, 2026 /EINPresswire.com/ — Madorra Inc., a medical device company developing innovative solutions for menopause-related conditions, today announced the enrollment of the first patient in... Read More →
A method of comprehensive sequencing analysis of the small RNA fragmentome (RiboMarker) featuring RealSeq Biosciences
Abstract Circulating cell-free nucleic acids (cfDNA and cfRNA) found in blood and other biofluids are promising biomarkers for cancer. However, current methods exploiting tumor-derived cfDNA (ctDNA) are not sensitive enough in detecting minimal residual disease and early stages of cancer... Read More →
CNN Exclusive: The futuristic foam that stops deadly internal bleeding
CNN spoke with the first person in the world to be treated with this futuristic material, called Res-Q-Foam, after he was seriously injured in a car crash last year and had just moments to live. Watch
Anumana Secures FDA Clearance for First-of-Its-Kind ECG-AI Algorithm for Early Detection of Pulmonary Hypertension
CAMBRIDGE, Mass. – March 28, 2026 – Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled software-as-a-medical-device (SaMD) that detects early signs of PH, a... Read More →
How Genalyte Is Turning Same-Visit Diagnostics Into Lifesaving Decisions
Patient Stories: How MedTech Innovator alumni are transforming lives At MedTech Innovator we empower healthtech companies to bring groundbreaking solutions to patients in need. Our Patient Stories series highlights the real-world clinical impact of the companies we support—showcasing how their... Read More →
Starlight Cardiovascular Announces First Baby in the World Treated with Lifeline Stent System at Cincinnati Children’s Hospital
SAN DIEGO, March 24, 2026 /PRNewswire/ — Starlight Cardiovascular announced that the first baby in the world was treated with its Lifeline™ Ductus Arteriosus Stent System at Cincinnati Children’s Hospital in January. The device is currently being studied under a... Read More →